[Successful primary infliximab treatment of orofacial Crohn's disease without gastrointestinal manifestation].

MLA

Jung, Bo Yong, et al. “[Successful Primary Infliximab Treatment of Orofacial Crohn’s Disease without Gastrointestinal Manifestation].” The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi, vol. 59, no. 6, June 2012, pp. 437–40. EBSCOhost, https://doi.org/10.4166/kjg.2012.59.6.437.

APA

Jung, B. Y., Lee, S.-H., Chung, S. K., Lee, C. K., Lee, T. H., Chung, I.-K., Kim, S.-J., & Cho, H.-D. (2012). [Successful primary infliximab treatment of orofacial Crohn’s disease without gastrointestinal manifestation]. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi, 59(6), 437–440. https://doi.org/10.4166/kjg.2012.59.6.437

Chicago

Jung, Bo Yong, Suck-Ho Lee, Seung Kyu Chung, Chang Kyun Lee, Tae Hoon Lee, Il-Kwun Chung, Sun-Joo Kim, and Hyun-Deuk Cho. 2012. “[Successful Primary Infliximab Treatment of Orofacial Crohn’s Disease without Gastrointestinal Manifestation].” The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi 59 (6): 437–40. doi:10.4166/kjg.2012.59.6.437.